Post by Lonza

What will it take to unlock the next wave of investment in extracellular vesicle (EV) therapeutics? Lonza recently brought together investors, biotech leaders and industry experts in Boston to discuss the future of the field. From scientific and clinical progress to manufacturing readiness and investment trends, the conversations explored the opportunities and challenges shaping the next phase of EV therapeutics. Thank you to everyone who joined us and contributed to an open and insightful discussion. Looking to advance your extracellular vesicle program? Connect with our team to explore how Lonza can support your development and manufacturing journey. https://lnkd.in/eMYDVTmU

Video Content